BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7016369)

  • 1. Enzyme immunoassay for specific determination of the synthetic estrogen, ethynyl estradiol, in plasma.
    Turkes A; Dyas J; Read GF; Riad-Fahmy D
    Clin Chem; 1981 Jun; 27(6):901-5. PubMed ID: 7016369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
    Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
    Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.
    Stanczyk FZ; Gale JA; Goebelsmann U; Nerenberg C; Matin S
    Contraception; 1980 Nov; 22(5):457-70. PubMed ID: 7471737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive solid phase enzymeimmunoassay for norethisterone (norethindrone) in saliva and plasma.
    Turkes A; Dyas J; Read GF; Riad-Fahmy D
    Steroids; 1980 Apr; 35(4):445-57. PubMed ID: 6990558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioimmunoassay for ethinyl oestradiol in plasma incorporating an immunosorbent, pre-assay purification procedure.
    Dyas J; Turkes A; Read GF; Riad-Fahmy D
    Ann Clin Biochem; 1981 Jan; 18(Pt 1):37-41. PubMed ID: 7259063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
    Rogers SM; Back DJ; Stevenson PJ; Grimmer SF; Orme ML
    Br J Clin Pharmacol; 1987 Jun; 23(6):721-5. PubMed ID: 3111513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human urinary and liver conjugates of 17alpha-ethnylestradiol.
    Helton ED; Williams MC; Goldzieher JW
    Steroids; 1976 Jun; 27(6):851-67. PubMed ID: 941195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved enzyme immunoassay for progesterone in human plasma.
    Joyce BG; Wilson DW; Read GF; Riad-Fahmy R
    Clin Chem; 1978 Dec; 24(12):2099-102. PubMed ID: 363304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple high-throughput enzymeimmunoassay for norethisterone (norethindrone).
    Turkes A; Read GF; Riad-Fahmy D
    Contraception; 1982 May; 25(5):505-14. PubMed ID: 7049571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
    Zacur HA; Burkman RT; Kimball AW; Kwiterovich P; Bell WR
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1268-72. PubMed ID: 1430087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a radioimmunoassay method for ethynylestradiol in plasma using a monoclonal antibody.
    Agasan AL; Stewart BJ; Watson TG
    J Immunol Methods; 1994 Dec; 177(1-2):251-60. PubMed ID: 7822832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a monoclonal antibody for use in radioimmunoassay of ethynylestradiol.
    Agasan AL; Briggs MH; Hewish DR; Stewart B
    Steroids; 1986; 47(4-5):295-306. PubMed ID: 2438822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary metabolites of 17alpha-ethynylestradiol-9alpha,11xi-3H in women. Chromatographic profiling and indentification of ethynyl and non-ethynyl compounds.
    Williams MC; Helton ED; Goldzieher JW
    Steroids; 1975 Feb; 25(2):229-46. PubMed ID: 164063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.